CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Feb 15, 2023 | Sale | $8.34 | 3,762 | 31,375 | 173,061 | Feb 16, 2023, 08:48 AM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Jan 30, 2023 | Sale | $8.35 | 10,106 | 84,385 | 176,823 | Jan 31, 2023, 08:28 AM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Jan 06, 2023 | Sale | $7.25 | 2,893 | 20,974 | 186,929 | Jan 09, 2023, 04:13 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Feb 14, 2022 | Sale | $3.09 | 3,762 | 11,625 | 189,822 | Feb 16, 2022, 08:01 AM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Jan 05, 2022 | Sale | $3.19 | 2,894 | 9,232 | 83,084 | Jan 07, 2022, 04:17 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Aug 16, 2021 | Sale | $3.28 | 8,086 | 26,522 | 85,978 | Aug 17, 2021, 04:02 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Feb 16, 2021 | Sale | $7.32 | 3,763 | 27,545 | 94,064 | Feb 17, 2021, 09:27 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Aug 17, 2020 | Sale | $10.37 | 4,354 | 45,151 | 76,127 | Aug 19, 2020, 05:44 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Mar 31, 2019 | Option Exercise | $12.07 | 8,835 | 106,638 | 21,165 | Apr 02, 2019, 04:15 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Apr 17, 2018 | Sale | $20.18 | 10,582 | 213,510 | 30,000 | Apr 19, 2018, 04:07 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Mar 31, 2018 | Option Exercise | $22.90 | 4,418 | 101,172 | 40,582 | Apr 13, 2018, 04:51 PM |
CNCE | | CONCERT PHARMACEUTICALS, INC. | Cassella James V | Chief Development Officer | Mar 31, 2018 | Option Exercise | $22.90 | 4,418 | 101,172 | 55,582 | Apr 03, 2018, 04:20 PM |
ALXA | | Alexza Pharmaceuticals Inc. | Cassella James V | EVP, R&D and CSO | Mar 29, 2013 | Option Exercise | $4.42 | 43,750 | 193,375 | 62,495 | Apr 02, 2013, 08:07 PM |
ALXA | | Alexza Pharmaceuticals Inc. | Cassella James V | EVP, R&D and CSO | Mar 29, 2013 | Option Exercise | $4.42 | 43,750 | 193,375 | 62,495 | Apr 02, 2013, 05:28 PM |
ALXA | | Alexza Pharmaceuticals Inc. | Cassella James V | EVP, R&D and CSO | Dec 26, 2012 | Sale | $4.90 | 4,558 | 22,316 | 950 | Dec 27, 2012, 04:19 PM |
ALXA | | Alexza Pharmaceuticals Inc. | Cassella James V | EVP, R&D and CSO | Aug 27, 2012 | Sale | $4.14 | 10,000 | 41,364 | 5,508 | Aug 29, 2012, 05:39 PM |
ALXA | | Alexza Pharmaceuticals Inc. | Cassella James V | SVP, Research & Development | Jun 06, 2012 | Sale | $0.34 | 46,222 | 15,628 | 157,801 | Jun 08, 2012, 04:56 PM |